Determinants of Short-Term Survival After Heart Transplantation in Patients Bridged to Transplant With Left Ventricular Assist Device.

IF 0.8
Suat Şenkaya, Ümit Kahraman, Ayşen Yaprak Kapkın, Özlem Balcıoğlu, Sanem Nalbantgil, Çağatay Engin, Tahir Yağdı, Mustafa Özbaran
{"title":"Determinants of Short-Term Survival After Heart Transplantation in Patients Bridged to Transplant With Left Ventricular Assist Device.","authors":"Suat Şenkaya, Ümit Kahraman, Ayşen Yaprak Kapkın, Özlem Balcıoğlu, Sanem Nalbantgil, Çağatay Engin, Tahir Yağdı, Mustafa Özbaran","doi":"10.1016/j.transproceed.2025.08.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The bridge to heart transplantation has been the subject of intense debate. This study aimed to determine the factors affecting early survival after bridge to heart transplantation.</p><p><strong>Methods: </strong>Between 2011 and 2019, patients who underwent a bridge to heart transplantation in a single center were retrospectively scanned. Demographics, complications of left ventricular assist device (LVAD), cardiopulmonary bypass (CPB), and cross-clamp duration, use of blood products, length of ventricular assist device (VAD) support, post-transplant hospital stay, post-transplant complications, and in-hospital mortality rates were recorded.</p><p><strong>Results: </strong>Patients (n = 60) were divided into 2 groups; patients with 30-day mortality (group 1, n = 10) and those with survival longer than 30 days (group 2, n = 50). The patients in group 1 were found to be older (P = .009), supported for a longer duration (P = .027), have higher International Normalized Ratio (INR) levels (P = .025), and have device-specific infection more commonly (P = .003). Cardiac ischemia (P = .013) and CPB (P = .006) durations were longer in group 1. Use of blood products and nitric oxide (NO) was more frequent in group 1 (P < .05). Post-transplantation complications (stroke, sepsis, kidney failure, arrhythmia, need for intra-aortic balloon pump [IABP], and short-term mechanical circulatory support [MCS]) were significantly more common in group 1 patients (P < .05). Blood products (0.920 for red blood cells, 0.901 for fresh frozen plasma, and 0.885 for platelets), postoperative high creatinine (0.817) and lactate (0.715), and device-specific infection (0.686) had the highest area under the curve values in the receiver operating characteristic (ROC).</p><p><strong>Conclusions: </strong>Bridge to transplantation has its own challenges of being a reoperation under high INR levels. Recurrent infection attacks and an inflammatory state may be limiting the healing process. Device-specific infection may be a major reason for early mortality whereas it is also a major indication for urging heart transplantation.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2025.08.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The bridge to heart transplantation has been the subject of intense debate. This study aimed to determine the factors affecting early survival after bridge to heart transplantation.

Methods: Between 2011 and 2019, patients who underwent a bridge to heart transplantation in a single center were retrospectively scanned. Demographics, complications of left ventricular assist device (LVAD), cardiopulmonary bypass (CPB), and cross-clamp duration, use of blood products, length of ventricular assist device (VAD) support, post-transplant hospital stay, post-transplant complications, and in-hospital mortality rates were recorded.

Results: Patients (n = 60) were divided into 2 groups; patients with 30-day mortality (group 1, n = 10) and those with survival longer than 30 days (group 2, n = 50). The patients in group 1 were found to be older (P = .009), supported for a longer duration (P = .027), have higher International Normalized Ratio (INR) levels (P = .025), and have device-specific infection more commonly (P = .003). Cardiac ischemia (P = .013) and CPB (P = .006) durations were longer in group 1. Use of blood products and nitric oxide (NO) was more frequent in group 1 (P < .05). Post-transplantation complications (stroke, sepsis, kidney failure, arrhythmia, need for intra-aortic balloon pump [IABP], and short-term mechanical circulatory support [MCS]) were significantly more common in group 1 patients (P < .05). Blood products (0.920 for red blood cells, 0.901 for fresh frozen plasma, and 0.885 for platelets), postoperative high creatinine (0.817) and lactate (0.715), and device-specific infection (0.686) had the highest area under the curve values in the receiver operating characteristic (ROC).

Conclusions: Bridge to transplantation has its own challenges of being a reoperation under high INR levels. Recurrent infection attacks and an inflammatory state may be limiting the healing process. Device-specific infection may be a major reason for early mortality whereas it is also a major indication for urging heart transplantation.

左心室辅助装置桥接心脏移植患者短期生存的决定因素。
背景:通往心脏移植的桥梁一直是激烈争论的主题。本研究旨在确定影响心脏桥移植术后早期生存的因素。方法:在2011年至2019年期间,对在单一中心接受心脏移植桥接手术的患者进行回顾性扫描。记录人口统计学、左心室辅助装置(LVAD)、体外循环(CPB)和交叉钳夹时间的并发症、血液制品的使用、心室辅助装置(VAD)支持的时间、移植后住院时间、移植后并发症和住院死亡率。结果:60例患者分为2组;30天死亡率患者(组1,n = 10)和生存时间超过30天的患者(组2,n = 50)。1组患者年龄较大(P = 0.009),支持时间较长(P = 0.027),国际标准化比率(INR)水平较高(P = 0.025),器械特异性感染发生率较高(P = 0.003)。1组心脏缺血(P = 0.013)和CPB (P = 0.006)持续时间较长。1组患者使用血液制品和一氧化氮(NO)的频率更高(P < 0.05)。移植后并发症(中风、败血症、肾衰竭、心律失常、需要主动脉内球囊泵[IABP]和短期机械循环支持[MCS])在1组患者中更为常见(P < 0.05)。血制品(红细胞0.920,新鲜冷冻血浆0.901,血小板0.885)、术后高肌酐(0.817)和乳酸(0.715)、器械特异性感染(0.686)在受试者工作特征(ROC)曲线下面积最大。结论:在高INR水平下,再手术的桥接移植面临着自身的挑战。复发性感染和炎症状态可能会限制愈合过程。器械特异性感染可能是早期死亡的主要原因,同时也是催促心脏移植的主要指征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信